Last 12 months
Inside the activity.
1 purchase rows · 32 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 8 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 17, 2017 Filed Apr 18, 2017 23:57 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionCommon Stock | 10,090 | $9.91 | $99,991.90 |
DisclosureSEC source: 0000939767-17-000063 · wf-form4_149255983275104.xml · nonDerivative · entry 1 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2017. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 00:00 UTC |
MARCHESI VINCENT TDirector
|
Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0000939767-17-000053 · wf-form4_149135043435843.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 00:00 UTC |
MARCHESI VINCENT TDirector
|
SaleCommon Stock | 10,000 | $21.30 | $213,000.00 |
DisclosureSEC source: 0000939767-17-000053 · wf-form4_149135043435843.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,070 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2016. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.07 to $21.64. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 00:00 UTC |
MARCHESI VINCENT TDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.53 | $105,300.00 |
DisclosureSEC source: 0000939767-17-000053 · wf-form4_149135043435843.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2017 Filed Mar 31, 2017 22:35 UTC |
WYSZOMIERSKI JACK LDirector
|
Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0000939767-17-000051 · wf-form4_149099971426992.xml · derivative · entry 3 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007. Read SEC document |
| March 31, 2017 Filed Mar 31, 2017 22:35 UTC |
WYSZOMIERSKI JACK LDirector
|
SaleCommon Stock | 5,150 | $21.57 | $111,085.50 |
DisclosureSEC source: 0000939767-17-000051 · wf-form4_149099971426992.xml · nonDerivative · entry 2 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,960 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.32 to $21.73. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 31, 2017 Filed Mar 31, 2017 22:35 UTC |
WYSZOMIERSKI JACK LDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.53 | $105,300.00 |
DisclosureSEC source: 0000939767-17-000051 · wf-form4_149099971426992.xml · nonDerivative · entry 1 WYSZOMIERSKI JACK L · CIK 0001023225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 00:15 UTC |
COHEN CHARLESDirector
|
Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0000939767-17-000049 · wf-form4_149074654060658.xml · derivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 00:15 UTC |
COHEN CHARLESDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.53 | $105,300.00 |
DisclosureSEC source: 0000939767-17-000049 · wf-form4_149074654060658.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 00:15 UTC |
Hessekiel JeffreyEVP and General Counsel
|
SaleCommon Stock | 6,884 | $21.02 | $144,701.68 |
DisclosureSEC source: 0000939767-17-000048 · wf-form4_149074648798636.xml · nonDerivative · entry 1 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,946 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.03. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 16,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 22, 2017 Filed Mar 24, 2017 23:41 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionOption (right to buy) · Derivative | 55,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-17-000045 · wf-form4_149039885489826.xml · derivative · entry 4 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock · 55,000 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became exercisable as to fifty percent (50%) of the shares subject to the option on July 20, 2015, as to twenty-five (25%) of the shares subject to the option on March 7, 2016 and as to the remaining twenty-five (25%) of the shares subject to the option on April 28, 2016. Read SEC document |
| March 22, 2017 Filed Mar 24, 2017 23:41 UTC |
Hessekiel JeffreyEVP and General Counsel
|
SaleCommon Stock | 23,787 | $20.54 | $488,584.98 |
DisclosureSEC source: 0000939767-17-000045 · wf-form4_149039885489826.xml · nonDerivative · entry 2 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,830 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.53 to $20.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 22, 2017 Filed Mar 24, 2017 23:41 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionCommon Stock | 55,000 | $1.70 | $93,500.00 |
DisclosureSEC source: 0000939767-17-000045 · wf-form4_149039885489826.xml · nonDerivative · entry 1 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 16,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 23:29 UTC |
FELDBAUM CARL BDirector
|
Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0000939767-17-000043 · wf-form4_149013897850089.xml · derivative · entry 3 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 23:29 UTC |
FELDBAUM CARL BDirector
|
SaleCommon Stock | 10,000 | $21.77 | $217,700.00 |
DisclosureSEC source: 0000939767-17-000043 · wf-form4_149013897850089.xml · nonDerivative · entry 2 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,721 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.76 to $21.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 23:29 UTC |
FELDBAUM CARL BDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.53 | $105,300.00 |
DisclosureSEC source: 0000939767-17-000043 · wf-form4_149013897850089.xml · nonDerivative · entry 1 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 23:28 UTC |
PAPADOPOULOS STELIOSDirector
|
Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0000939767-17-000042 · wf-form4_149013890413147.xml · derivative · entry 4 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 23:28 UTC |
PAPADOPOULOS STELIOSDirector
|
SaleCommon Stock | 10,000 | $21.66 | $216,600.00 |
DisclosureSEC source: 0000939767-17-000042 · wf-form4_149013890413147.xml · nonDerivative · entry 2 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228,471 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.66 to $21.68. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 23:28 UTC |
PAPADOPOULOS STELIOSDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.53 | $105,300.00 |
DisclosureSEC source: 0000939767-17-000042 · wf-form4_149013890413147.xml · nonDerivative · entry 1 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,238,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2017 Filed Mar 24, 2017 23:41 UTC |
Hessekiel JeffreyEVP and General Counsel
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-17-000045 · wf-form4_149039885489826.xml · nonDerivative · entry 3 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,830 Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:52 UTC |
WILLSEY LANCEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0000939767-17-000039 · wf-form4_148979474359671.xml · derivative · entry 3 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:52 UTC |
WILLSEY LANCEDirector
|
SaleCommon Stock | 10,000 | $22.86 | $228,600.00 |
DisclosureSEC source: 0000939767-17-000039 · wf-form4_148979474359671.xml · nonDerivative · entry 2 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,273 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.85 to $22.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:52 UTC |
WILLSEY LANCEDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.53 | $105,300.00 |
DisclosureSEC source: 0000939767-17-000039 · wf-form4_148979474359671.xml · nonDerivative · entry 1 WILLSEY LANCE · CIK 0001202106 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:51 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionOption (right to buy) · Derivative | 32,300 | $0.00 Strike: $7.18 | $0.00 |
DisclosureSEC source: 0000939767-17-000038 · wf-form4_148979469607480.xml · derivative · entry 6 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,700 Underlying: Common Stock · 32,300 shares Expires 2019-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 210,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 9, 2013. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:51 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionOption (right to buy) · Derivative | 17,707 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0000939767-17-000038 · wf-form4_148979469607480.xml · derivative · entry 5 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,293 Underlying: Common Stock · 17,707 shares Expires 2019-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 26, 2013. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:51 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
SaleCommon Stock | 50,007 | $22.53 | $1,126,657.71 |
DisclosureSEC source: 0000939767-17-000038 · wf-form4_148979469607480.xml · nonDerivative · entry 3 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,053 Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:51 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionCommon Stock | 32,300 | $7.18 | $231,914.00 |
DisclosureSEC source: 0000939767-17-000038 · wf-form4_148979469607480.xml · nonDerivative · entry 2 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 23:51 UTC |
Schwab GiselaPres Prod Dev & Med Aff & CMO
|
Exercise / conversionCommon Stock | 17,707 | $4.42 | $78,264.94 |
DisclosureSEC source: 0000939767-17-000038 · wf-form4_148979469607480.xml · nonDerivative · entry 1 Schwab Gisela · CIK 0001213140 · Pres Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 20,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 00:12 UTC |
COHEN CHARLESDirector
|
SaleCommon Stock | 10,000 | $21.82 | $218,200.00 |
DisclosureSEC source: 0000939767-17-000035 · wf-form4_148953671883702.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,180 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.81 to $21.83. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 00:37 UTC |
MARCHESI VINCENT TDirector
|
Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0000939767-17-000033 · wf-form4_148919262208619.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2022-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015. Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 00:37 UTC |
MARCHESI VINCENT TDirector
|
SaleCommon Stock | 40,000 | $21.98 | $879,200.00 |
DisclosureSEC source: 0000939767-17-000033 · wf-form4_148919262208619.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,070 Read SEC document |
| March 10, 2017 Filed Mar 11, 2017 00:37 UTC |
MARCHESI VINCENT TDirector
|
Exercise / conversionCommon Stock | 40,000 | $3.13 | $125,200.00 |
DisclosureSEC source: 0000939767-17-000033 · wf-form4_148919262208619.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 00:56 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $9.91 | $0.00 |
DisclosureSEC source: 0000939767-17-000030 · wf-form4_148893456375147.xml · derivative · entry 8 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2017-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2011. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 00:56 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
SaleCommon Stock | 100,000 | $22.61 | $2,261,000.00 |
DisclosureSEC source: 0000939767-17-000030 · wf-form4_148893456375147.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.50 to $22.69. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 00:56 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 100,000 | $9.91 | $991,000.00 |
DisclosureSEC source: 0000939767-17-000030 · wf-form4_148893456375147.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 4, 2017 01:20 UTC |
Senner Christopher J.EVP and CFO
|
SaleCommon Stock | 11,000 | $22.80 | $250,800.00 |
DisclosureSEC source: 0000939767-17-000025 · wf-form4_148859039767320.xml · nonDerivative · entry 1 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,398 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.80 to $22.81. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 20,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 5,422 shares of common stock acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. The total number of shares reported has been reduced by 20,000 shares due to prior inadvertent over-reporting of the total number of shares beneficially owned by the Reporting Person. Read SEC document |
| March 03, 2017 Filed Mar 8, 2017 00:56 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $9.91 | $0.00 |
DisclosureSEC source: 0000939767-17-000030 · wf-form4_148893456375147.xml · derivative · entry 7 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2017-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2011. Read SEC document |
| March 03, 2017 Filed Mar 8, 2017 00:56 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
SaleCommon Stock | 100,000 | $22.83 | $2,283,000.00 |
DisclosureSEC source: 0000939767-17-000030 · wf-form4_148893456375147.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.80 to $22.94. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 03, 2017 Filed Mar 8, 2017 00:56 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 100,000 | $9.91 | $991,000.00 |
DisclosureSEC source: 0000939767-17-000030 · wf-form4_148893456375147.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 60,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 03, 2017 Filed Mar 8, 2017 01:00 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0000939767-17-000031 · wf-form4_148893478684185.xml · derivative · entry 5 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 100,000 shares Expires 2021-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 230,000 shares of Exelixis, Inc. common stock, was exercisable as to 172,500 shares on the Transaction Date. The remainder of the option will vest as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the February 10, 2014 grant date. Read SEC document |
| March 03, 2017 Filed Mar 8, 2017 01:00 UTC |
Hessekiel JeffreyEVP and General Counsel
|
SaleCommon Stock | 59,482 | $23.05 | $1,371,060.10 |
DisclosureSEC source: 0000939767-17-000031 · wf-form4_148893478684185.xml · nonDerivative · entry 4 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,617 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.03 to $23.14. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| March 03, 2017 Filed Mar 8, 2017 01:00 UTC |
Hessekiel JeffreyEVP and General Counsel
|
SaleCommon Stock | 3,519 | $23.20 | $81,640.80 |
DisclosureSEC source: 0000939767-17-000031 · wf-form4_148893478684185.xml · nonDerivative · entry 3 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,099 Read SEC document |
| March 03, 2017 Filed Mar 8, 2017 01:00 UTC |
Hessekiel JeffreyEVP and General Counsel
|
SaleCommon Stock | 36,999 | $23.00 | $850,977.00 |
DisclosureSEC source: 0000939767-17-000031 · wf-form4_148893478684185.xml · nonDerivative · entry 2 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,618 Read SEC document |
| March 03, 2017 Filed Mar 8, 2017 01:00 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionCommon Stock | 100,000 | $7.27 | $727,000.00 |
DisclosureSEC source: 0000939767-17-000031 · wf-form4_148893478684185.xml · nonDerivative · entry 1 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 16,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 03, 2017 Filed Mar 8, 2017 00:45 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 2,500 | $23.04 | $57,600.00 |
DisclosureSEC source: 0000939767-17-000029 · wf-form4_148893391828401.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,193 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.0359 to $23.045. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. F2 · balance_after: Includes 27,553 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| March 02, 2017 Filed Mar 4, 2017 01:17 UTC |
POSTE GEORGEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-17-000023 · wf-form4_148859021275410.xml · derivative · entry 12 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008. Read SEC document |
| March 02, 2017 Filed Mar 4, 2017 01:17 UTC |
POSTE GEORGEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 11,250 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000939767-17-000023 · wf-form4_148859021275410.xml · derivative · entry 11 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires 2019-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 11,250 shares of Exelixis, Inc. common stock, became fully exercisable on May 14, 2009. Read SEC document |
| March 02, 2017 Filed Mar 4, 2017 01:17 UTC |
POSTE GEORGEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0000939767-17-000023 · wf-form4_148859021275410.xml · derivative · entry 10 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2022-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015. Read SEC document |
| March 02, 2017 Filed Mar 4, 2017 01:17 UTC |
POSTE GEORGEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 1,150 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0000939767-17-000023 · wf-form4_148859021275410.xml · derivative · entry 9 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,150 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007. Read SEC document |
| March 02, 2017 Filed Mar 4, 2017 01:17 UTC |
POSTE GEORGEDirector
|
SaleCommon Stock | 67,400 | $22.58 | $1,521,892.00 |
DisclosureSEC source: 0000939767-17-000023 · wf-form4_148859021275410.xml · nonDerivative · entry 7 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,555 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.40 to $22.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.